Bill of the Month
KFF Health News, in collaboration with The Washington Post, examines and decodes your perplexing medical bills.
Investigations
Priced Out
America’s Health Insurance Crisis
Common Ground
Americans are split over many issues, but helping people with cancer and other serious illnesses retains broad bipartisan support.
441 - 450 of 450 Results
-
Treating Cancer: Hope Vs. Hype
Sticker Shock Forces Thousands Of Cancer Patients To Skip Drugs, Skimp On Treatment
A growing number of patients fail to fill prescriptions because the cost of cancer drugs is too high.
By Liz Szabo -
Grassley Launches Inquiry Into Orphan Drugs After KHN Investigation
Citing a Kaiser Health News investigation, Senate Judiciary Committee Chairman Chuck Grassley vows to examine the orphan drug program and possible fixes.
-
Repeal & Replace Watch
HHS Pick Price Made ‘Brazen’ Stock Trades While His Committee Was Under Scrutiny
With federal investigators bearing down on his committee, Rep. Tom Price, R-Ga., who is line to be secretary of the Department of Health and Human Services, showed little restraint in investing in health companies.
By Marisa Taylor and Christina Jewett -
Women Fear Drug They Used To Halt Puberty Led To Health Problems
Despite questions about Lupron’s lasting side effects and minimal study into its safety, the FDA sped approval of the drug to market. Years later, some young women are still living with the consequences.
-
The Orphan Drug Machine
Sky-High Prices For Orphan Drugs Slam American Families And Insurers
Orphan drugs for rare diseases have helped or saved hundreds of thousands of patients like 2-year-old Luke Whitbeck, but families and insurers are picking up the astronomical cost.
By Sarah Jane Tribble and Sydney Lupkin -
The Orphan Drug Machine
Drugmakers Manipulate Orphan Drug Rules To Create Prized Monopolies
Drugmakers have brought almost 450 orphan drugs to market and collected rich incentives but nearly a third of those products aren’t new or were repurposed multiple times, an investigation shows.
By Sarah Jane Tribble and Sydney Lupkin -
Repeal & Replace Watch
Top Price Contributor Allegedly Leaned On Employees To Support PAC
President-elect Donald Trump’s Cabinet pick Tom Price "assisted" a company and campaign donor who tapped executives with an urgent request to donate.
By Marisa Taylor and Christina Jewett -
Trump’s HHS Nominee Got A Sweetheart Deal From A Foreign Biotech Firm
Price and another influential GOP congressman got a discounted deal as an Australian firm seeking federal approval sought “sophisticated U.S. investors.”
By Jay Hancock and Rachel Bluth -
Trump’s Health Secretary Nominee Sought Special Treatment for Industry Donors
Rep. Tom Price advocated on everything from a sperm test to a hot pepper ingredient on behalf of medical interests that included campaign donors.
By Marisa Taylor and Christina Jewett -
Victims Seek Payments As ‘Dr. Death’ Declares Innocence
While hundreds of his former patients submit claims for restitution, a Detroit cancer doctor convicted of making millions by purposefully poisoning them with drugs they didn’t need vows to prove his innocence.